ID   LATS2_HUMAN             Reviewed;        1088 AA.
AC   Q9NRM7; B1AM47; Q9P2X1;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   04-NOV-2008, sequence version 2.
DT   10-MAY-2017, entry version 159.
DE   RecName: Full=Serine/threonine-protein kinase LATS2;
DE            EC=2.7.11.1;
DE   AltName: Full=Kinase phosphorylated during mitosis protein;
DE   AltName: Full=Large tumor suppressor homolog 2;
DE   AltName: Full=Serine/threonine-protein kinase kpm;
DE   AltName: Full=Warts-like kinase;
GN   Name=LATS2 {ECO:0000312|EMBL:BAA92381.1}; Synonyms=KPM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAF80561.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY,
RP   AUTOPHOSPHORYLATION, AND MUTAGENESIS OF LYS-697.
RC   TISSUE=Myeloid {ECO:0000312|EMBL:AAF80561.1};
RX   PubMed=10871863; DOI=10.1038/sj.onc.1203659;
RA   Hori T., Takaori-Kondo A., Kamikubo Y., Uchiyama T.;
RT   "Molecular cloning of a novel human protein kinase, kpm, that is
RT   homologous to warts/lats, a Drosophila tumor suppressor.";
RL   Oncogene 19:3101-3109(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000305, ECO:0000312|EMBL:BAA92381.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 42-1088, TISSUE SPECIFICITY, AND VARIANT
RP   VAL-324.
RC   TISSUE=Testis {ECO:0000269|PubMed:10673337};
RX   PubMed=10673337; DOI=10.1006/geno.1999.6065;
RA   Yabuta N., Fujii T., Copeland N.G., Gilbert D.J., Jenkins N.A.,
RA   Nishiguchi H., Endo Y., Toji S., Tanaka H., Nishimune Y., Nojima H.;
RT   "Structure, expression, and chromosome mapping of LATS2, a mammalian
RT   homologue of the Drosophila tumor suppressor gene lats/warts.";
RL   Genomics 63:263-270(2000).
RN   [6] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-697 AND
RP   SER-872.
RX   PubMed=12853976; DOI=10.1038/sj.onc.1206603;
RA   Li Y., Pei J., Xia H., Ke H., Wang H., Tao W.;
RT   "Lats2, a putative tumor suppressor, inhibits G1/S transition.";
RL   Oncogene 22:4398-4405(2003).
RN   [7] {ECO:0000305}
RP   SUBCELLULAR LOCATION, INTERACTION WITH AURKA, MUTAGENESIS OF SER-83,
RP   AND PHOSPHORYLATION AT SER-83.
RX   PubMed=15147269; DOI=10.1111/j.1356-9597.2004.00732.x;
RA   Toji S., Yabuta N., Hosomi T., Nishihara S., Kobayashi T., Suzuki S.,
RA   Tamai K., Nojima H.;
RT   "The centrosomal protein Lats2 is a phosphorylation target of Aurora-A
RT   kinase.";
RL   Genes Cells 9:383-397(2004).
RN   [8] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH AR.
RX   PubMed=15131260; DOI=10.1210/me.2004-0065;
RA   Powzaniuk M., McElwee-Witmer S., Vogel R.L., Hayami T., Rutledge S.J.,
RA   Chen F., Harada S., Schmidt A., Rodan G.A., Freedman L.P., Bai C.;
RT   "The LATS2/KPM tumor suppressor is a negative regulator of the
RT   androgen receptor.";
RL   Mol. Endocrinol. 18:2011-2023(2004).
RN   [9]
RP   PHOSPHORYLATION.
RX   PubMed=15688006; DOI=10.1038/sj.onc.1208445;
RA   Chan E.H.Y., Nousiainen M., Chalamalasetty R.B., Schaefer A.,
RA   Nigg E.A., Sillje H.H.W.;
RT   "The Ste20-like kinase Mst2 activates the human large tumor suppressor
RT   kinase Lats1.";
RL   Oncogene 24:2076-2086(2005).
RN   [10]
RP   INTERACTION WITH AJUBA.
RX   PubMed=16413547; DOI=10.1016/j.febslet.2005.12.096;
RA   Abe Y., Ohsugi M., Haraguchi K., Fujimoto J., Yamamoto T.;
RT   "LATS2-Ajuba complex regulates gamma-tubulin recruitment to
RT   centrosomes and spindle organization during mitosis.";
RL   FEBS Lett. 580:782-788(2006).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH YAP1.
RX   PubMed=18158288; DOI=10.1074/jbc.M709037200;
RA   Hao Y., Chun A., Cheung K., Rashidi B., Yang X.;
RT   "Tumor suppressor LATS1 is a negative regulator of oncogene YAP.";
RL   J. Biol. Chem. 283:5496-5509(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-279, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   INTERACTION WITH LIMD1; WTIP AND AJUBA.
RX   PubMed=20303269; DOI=10.1016/j.cub.2010.02.035;
RA   Das Thakur M., Feng Y., Jagannathan R., Seppa M.J., Skeath J.B.,
RA   Longmore G.D.;
RT   "Ajuba LIM proteins are negative regulators of the Hippo signaling
RT   pathway.";
RL   Curr. Biol. 20:657-662(2010).
RN   [14]
RP   INTERACTION WITH MOB1A AND MOB1B.
RX   PubMed=19739119; DOI=10.1002/ijc.24878;
RA   Chow A., Hao Y., Yang X.;
RT   "Molecular characterization of human homologs of yeast MOB1.";
RL   Int. J. Cancer 126:2079-2089(2010).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH SNAI1, AND
RP   PHOSPHORYLATION AT THR-1041.
RX   PubMed=21952048; DOI=10.1038/emboj.2011.357;
RA   Zhang K., Rodriguez-Aznar E., Yabuta N., Owen R.J., Mingot J.M.,
RA   Nojima H., Nieto M.A., Longmore G.D.;
RT   "Lats2 kinase potentiates Snail1 activity by promoting nuclear
RT   retention upon phosphorylation.";
RL   EMBO J. 31:29-43(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-380 AND SER-576, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-40; LEU-91; VAL-799; GLY-1014 AND
RP   PRO-1025.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Negative regulator of YAP1 in the Hippo signaling
CC       pathway that plays a pivotal role in organ size control and tumor
CC       suppression by restricting proliferation and promoting apoptosis.
CC       The core of this pathway is composed of a kinase cascade wherein
CC       STK3/MST2 and STK4/MST1, in complex with its regulatory protein
CC       SAV1, phosphorylates and activates LATS1/2 in complex with its
CC       regulatory protein MOB1, which in turn phosphorylates and
CC       inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of
CC       YAP1 by LATS2 inhibits its translocation into the nucleus to
CC       regulate cellular genes important for cell proliferation, cell
CC       death, and cell migration. Acts as a tumor suppressor which plays
CC       a critical role in centrosome duplication, maintenance of mitotic
CC       fidelity and genomic stability. Negatively regulates G1/S
CC       transition by down-regulating cyclin E/CDK2 kinase activity.
CC       Negative regulator of the androgen receptor. Phosphorylates SNAI1
CC       in the nucleus leading to its nuclear retention and stabilization,
CC       which enhances its epithelial-mesenchymal transition and tumor
CC       cell invasion/migration activities. This tumor-promoting activity
CC       is independent of its effects upon YAP1 or WWTR1/TAZ.
CC       {ECO:0000269|PubMed:10871863, ECO:0000269|PubMed:12853976,
CC       ECO:0000269|PubMed:15131260, ECO:0000269|PubMed:18158288,
CC       ECO:0000269|PubMed:21952048}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:10871863}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- SUBUNIT: Interacts with and is phosphorylated by AURKA. Binds to
CC       AR. Interacts with AJUBA during mitosis and this complex regulates
CC       organization of the spindle apparatus through recruitment of
CC       gamma-tubulin to the centrosome. Interacts (via PPxY motif) with
CC       YAP1 (via WW domains). Interacts with MOB1A and MOB1B. Interacts
CC       with LIMD1, WTIP and AJUBA. Interacts with SNAI1.
CC       {ECO:0000269|PubMed:15131260, ECO:0000269|PubMed:15147269,
CC       ECO:0000269|PubMed:16413547, ECO:0000269|PubMed:18158288,
CC       ECO:0000269|PubMed:19739119, ECO:0000269|PubMed:20303269,
CC       ECO:0000269|PubMed:21952048}.
CC   -!- INTERACTION:
CC       Q96IF1:AJUBA; NbExp=6; IntAct=EBI-3506895, EBI-949782;
CC       Q13643:FHL3; NbExp=4; IntAct=EBI-3506895, EBI-741101;
CC       Q9H8S9:MOB1A; NbExp=4; IntAct=EBI-3506895, EBI-748229;
CC       Q7L9L4:MOB1B; NbExp=3; IntAct=EBI-3506895, EBI-2558745;
CC       Q9Y4B6:VPRBP; NbExp=2; IntAct=EBI-3506895, EBI-1996353;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome. Cytoplasm. Cytoplasm, cytoskeleton,
CC       spindle pole. Nucleus. Note=Colocalizes with AURKA at the
CC       centrosomes during interphase, early prophase and cytokinesis.
CC       Migrates to the spindle poles during mitosis, and to the midbody
CC       during cytokinesis. Translocates to the nucleus upon mitotic
CC       stress by nocodazole treatment.
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in heart and skeletal
CC       muscle and at lower levels in all other tissues examined.
CC       {ECO:0000269|PubMed:10673337, ECO:0000269|PubMed:10871863}.
CC   -!- PTM: Autophosphorylated and phosphorylated during M-phase and the
CC       G1/S-phase of the cell cycle. Phosphorylated and activated by
CC       STK3/MST2. {ECO:0000269|PubMed:15147269,
CC       ECO:0000269|PubMed:15688006, ECO:0000269|PubMed:21952048}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92381.1; Type=Frameshift; Positions=512, 526; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/LATS2ID41128ch13q12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF207547; AAF80561.1; -; mRNA.
DR   EMBL; AK314235; BAG36905.1; -; mRNA.
DR   EMBL; AL161613; CAH71526.1; -; Genomic_DNA.
DR   EMBL; AL356285; CAH71526.1; JOINED; Genomic_DNA.
DR   EMBL; AL356285; CAI15861.1; -; Genomic_DNA.
DR   EMBL; AL161613; CAI15861.1; JOINED; Genomic_DNA.
DR   EMBL; CH471075; EAX08286.1; -; Genomic_DNA.
DR   EMBL; AB028019; BAA92381.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS9294.1; -.
DR   RefSeq; NP_055387.2; NM_014572.2.
DR   RefSeq; XP_005266399.1; XM_005266342.1.
DR   UniGene; Hs.78960; -.
DR   PDB; 4ZRI; X-ray; 2.70 A; C/D=68-99.
DR   PDBsum; 4ZRI; -.
DR   ProteinModelPortal; Q9NRM7; -.
DR   SMR; Q9NRM7; -.
DR   BioGrid; 117727; 160.
DR   DIP; DIP-43883N; -.
DR   IntAct; Q9NRM7; 13.
DR   MINT; MINT-1772003; -.
DR   STRING; 9606.ENSP00000372035; -.
DR   BindingDB; Q9NRM7; -.
DR   ChEMBL; CHEMBL5907; -.
DR   GuidetoPHARMACOLOGY; 1516; -.
DR   iPTMnet; Q9NRM7; -.
DR   PhosphoSitePlus; Q9NRM7; -.
DR   BioMuta; LATS2; -.
DR   DMDM; 212276441; -.
DR   EPD; Q9NRM7; -.
DR   MaxQB; Q9NRM7; -.
DR   PaxDb; Q9NRM7; -.
DR   PeptideAtlas; Q9NRM7; -.
DR   PRIDE; Q9NRM7; -.
DR   DNASU; 26524; -.
DR   Ensembl; ENST00000382592; ENSP00000372035; ENSG00000150457.
DR   GeneID; 26524; -.
DR   KEGG; hsa:26524; -.
DR   UCSC; uc001unr.6; human.
DR   CTD; 26524; -.
DR   DisGeNET; 26524; -.
DR   GeneCards; LATS2; -.
DR   H-InvDB; HIX0022357; -.
DR   HGNC; HGNC:6515; LATS2.
DR   HPA; HPA039191; -.
DR   HPA; HPA049037; -.
DR   MIM; 604861; gene.
DR   neXtProt; NX_Q9NRM7; -.
DR   OpenTargets; ENSG00000150457; -.
DR   PharmGKB; PA30302; -.
DR   eggNOG; KOG0605; Eukaryota.
DR   eggNOG; ENOG410XQC0; LUCA.
DR   GeneTree; ENSGT00760000118994; -.
DR   HOGENOM; HOG000040002; -.
DR   HOVERGEN; HBG052311; -.
DR   InParanoid; Q9NRM7; -.
DR   KO; K08791; -.
DR   OMA; YGVQRSP; -.
DR   OrthoDB; EOG091G028J; -.
DR   PhylomeDB; Q9NRM7; -.
DR   TreeFam; TF351549; -.
DR   Reactome; R-HSA-2028269; Signaling by Hippo.
DR   SignaLink; Q9NRM7; -.
DR   SIGNOR; Q9NRM7; -.
DR   ChiTaRS; LATS2; human.
DR   GeneWiki; LATS2; -.
DR   GenomeRNAi; 26524; -.
DR   PRO; PR:Q9NRM7; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000150457; -.
DR   CleanEx; HS_LATS2; -.
DR   ExpressionAtlas; Q9NRM7; baseline and differential.
DR   Genevisible; Q9NRM7; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005815; C:microtubule organizing center; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0034613; P:cellular protein localization; IEA:Ensembl.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:UniProtKB.
DR   GO; GO:0035329; P:hippo signaling; IDA:BHF-UCL.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0001827; P:inner cell mass cell fate commitment; IEA:Ensembl.
DR   GO; GO:0001828; P:inner cell mass cellular morphogenesis; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0030216; P:keratinocyte differentiation; IEA:Ensembl.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:UniProtKB-KW.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0046620; P:regulation of organ growth; IBA:GO_Central.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like.
DR   Pfam; PF00069; Pkinase; 2.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell cycle; Cell division;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Kinase; Magnesium;
KW   Metal-binding; Mitosis; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Tumor suppressor.
FT   CHAIN         1   1088       Serine/threonine-protein kinase LATS2.
FT                                /FTId=PRO_0000086234.
FT   DOMAIN       98    139       UBA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00212}.
FT   DOMAIN      668    973       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      974   1052       AGC-kinase C-terminal.
FT   NP_BIND     674    782       ATP. {ECO:0000250|UniProtKB:P22612,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   MOTIF       515    518       PPxY motif.
FT   ACT_SITE    791    791       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:P22612,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159,
FT                                ECO:0000255|PROSITE-ProRule:PRU10027}.
FT   BINDING     697    697       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159,
FT                                ECO:0000269|PubMed:10871863}.
FT   MOD_RES      83     83       Phosphoserine; by AURKA.
FT                                {ECO:0000269|PubMed:15147269}.
FT   MOD_RES     279    279       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     380    380       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     576    576       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1041   1041       Phosphothreonine.
FT                                {ECO:0000269|PubMed:21952048}.
FT   VARIANT      40     40       G -> E (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040669.
FT   VARIANT      91     91       S -> L (in dbSNP:rs55842804).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040670.
FT   VARIANT     324    324       A -> V (in dbSNP:rs558614).
FT                                {ECO:0000269|PubMed:10673337}.
FT                                /FTId=VAR_019789.
FT   VARIANT     363    363       G -> S (in dbSNP:rs2770928).
FT                                /FTId=VAR_047077.
FT   VARIANT     799    799       I -> V (in dbSNP:rs35368391).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040671.
FT   VARIANT    1014   1014       A -> G (in dbSNP:rs45523141).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040672.
FT   VARIANT    1025   1025       L -> P (in dbSNP:rs56116059).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040673.
FT   MUTAGEN      83     83       S->C: Fails to localize at the centromere
FT                                during interphase.
FT                                {ECO:0000269|PubMed:15147269}.
FT   MUTAGEN      83     83       S->E: Fails to localize at the centromere
FT                                during interphase.
FT                                {ECO:0000269|PubMed:15147269}.
FT   MUTAGEN     697    697       K->A: Loss of kinase activity,
FT                                autophosphorylation and tumor suppressor
FT                                activity. {ECO:0000269|PubMed:10871863,
FT                                ECO:0000269|PubMed:12853976}.
FT   MUTAGEN     872    872       S->A: Loss of tumor suppressor activity.
FT                                {ECO:0000269|PubMed:12853976}.
FT   CONFLICT     59     61       RQQ -> SSK (in Ref. 5; BAA92381).
FT                                {ECO:0000305}.
FT   CONFLICT    436    436       T -> S (in Ref. 5; BAA92381).
FT                                {ECO:0000305}.
FT   CONFLICT    711    711       A -> V (in Ref. 1; AAF80561).
FT                                {ECO:0000305}.
FT   CONFLICT    868    868       C -> S (in Ref. 5; BAA92381).
FT                                {ECO:0000305}.
FT   HELIX        74     84       {ECO:0000244|PDB:4ZRI}.
FT   HELIX        85     87       {ECO:0000244|PDB:4ZRI}.
SQ   SEQUENCE   1088 AA;  120136 MW;  2866F6B75637AD36 CRC64;
     MRPKTFPATT YSGNSRQRLQ EIREGLKQPS KSSVQGLPAG PNSDTSLDAK VLGSKDATRQ
     QQQMRATPKF GPYQKALREI RYSLLPFANE SGTSAAAEVN RQMLQELVNA GCDQEMAGRA
     LKQTGSRSIE AALEYISKMG YLDPRNEQIV RVIKQTSPGK GLMPTPVTRR PSFEGTGDSF
     ASYHQLSGTP YEGPSFGADG PTALEEMPRP YVDYLFPGVG PHGPGHQHQH PPKGYGASVE
     AAGAHFPLQG AHYGRPHLLV PGEPLGYGVQ RSPSFQSKTP PETGGYASLP TKGQGGPPGA
     GLAFPPPAAG LYVPHPHHKQ AGPAAHQLHV LGSRSQVFAS DSPPQSLLTP SRNSLNVDLY
     ELGSTSVQQW PAATLARRDS LQKPGLEAPP RAHVAFRPDC PVPSRTNSFN SHQPRPGPPG
     KAEPSLPAPN TVTAVTAAHI LHPVKSVRVL RPEPQTAVGP SHPAWVPAPA PAPAPAPAPA
     AEGLDAKEEH ALALGGAGAF PLDVEYGGPD RRCPPPPYPK HLLLRSKSEQ YDLDSLCAGM
     EQSLRAGPNE PEGGDKSRKS AKGDKGGKDK KQIQTSPVPV RKNSRDEEKR ESRIKSYSPY
     AFKFFMEQHV ENVIKTYQQK VNRRLQLEQE MAKAGLCEAE QEQMRKILYQ KESNYNRLKR
     AKMDKSMFVK IKTLGIGAFG EVCLACKVDT HALYAMKTLR KKDVLNRNQV AHVKAERDIL
     AEADNEWVVK LYYSFQDKDS LYFVMDYIPG GDMMSLLIRM EVFPEHLARF YIAELTLAIE
     SVHKMGFIHR DIKPDNILID LDGHIKLTDF GLCTGFRWTH NSKYYQKGSH VRQDSMEPSD
     LWDDVSNCRC GDRLKTLEQR ARKQHQRCLA HSLVGTPNYI APEVLLRKGY TQLCDWWSVG
     VILFEMLVGQ PPFLAPTPTE TQLKVINWEN TLHIPAQVKL SPEARDLITK LCCSADHRLG
     RNGADDLKAH PFFSAIDFSS DIRKQPAPYV PTISHPMDTS NFDPVDEESP WNDASEGSTK
     AWDTLTSPNN KHPEHAFYEF TFRRFFDDNG YPFRCPKPSG AEASQAESSD LESSDLVDQT
     EGCQPVYV
//
